Assessing the comparative efficacy of plasmapheresis and Intravenous immunoglobulin in myasthenia gravis treatment: A systematic review and meta-analysis
- 1 February 2024
- journal article
- review article
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 121, 1-10
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A comparison between IVIG and plasma exchange as preparations before thymectomy in myasthenia gravis patientsActa Neurologica Belgica, 2016
- Report of the ASFA apheresis registry on muscle specific kinase antibody positive myasthenia gravisJournal of Clinical Apheresis, 2016
- Comparison of Plasmapheresis and Intravenous Immunoglobulin as Maintenance Therapies for Juvenile Myasthenia GravisJAMA Neurology, 2014
- Predictors of response to immunomodulation in patients with myasthenia gravisMuscle & Nerve, 2011
- Anti‐musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohortsMuscle & Nerve, 2011
- Comparative analysis of therapeutic options used for myasthenia gravisAnnals of Neurology, 2010
- Clinical findings in MuSK‐antibody positive myasthenia gravis: A U.S. experienceMuscle & Nerve, 2009
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravisAnnals of Neurology, 1997
- Myasthenic CrisisArchives of Neurology, 1993